A case of idiopathic nodular glomerulosclerosis successfully treated by intensive blockade of the renin-angiotensin-aldosterone system

CEN Case Rep. 2023 Aug;12(3):311-317. doi: 10.1007/s13730-022-00766-3. Epub 2022 Dec 27.

Abstract

Idiopathic nodular glomerulosclerosis has a poor renal prognosis and is characterized by diffuse nodular glomerulosclerotic lesions in the absence of diabetic mellitus. Here, we report the case of a 69-year-old woman with no smoking history who developed renal dysfunction and proteinuria in the absence of overt diabetes or obesity. A biopsy specimen showed nodular mesangial sclerosis with arteriolar hyalinosis and severe large-vessel arteriosclerosis, leading to a diagnosis of idiopathic nodular glomerulosclerosis. Addition of esaxerenone to her existing renin-angiotensin-aldosterone inhibitor therapy led to a rapid decrease in the proteinuria levels and the maintenance of renal function without any complications for more than a year. The results suggest that intensive renin-angiotensin-aldosterone blockade might be an effective treatment for idiopathic nodular glomerulosclerosis.

Keywords: Diabetes mellitus; Diabetic nephropathy; Idiopathic nodular glomerulosclerosis; Mineralocorticoid receptor blocker; Renal biopsy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aldosterone / pharmacology
  • Angiotensins / pharmacology
  • Arteriosclerosis* / complications
  • Arteriosclerosis* / pathology
  • Diabetic Nephropathies* / diagnosis
  • Female
  • Humans
  • Proteinuria / diagnosis
  • Proteinuria / drug therapy
  • Proteinuria / etiology
  • Renin
  • Renin-Angiotensin System

Substances

  • Renin
  • Aldosterone
  • Angiotensins